文献速递头颈外科

在调强放疗时代,前连合受累对早期声门癌是否仍有意义?

Does Anterior Commissure Involvement Matter for Early-Stage Glottic Cancer in the Intensity-Modulated Radiotherapy Era?
PubMed 文献 · Head Neck · 2025-06-13

该研究回顾性分析2000–2024年154例接受根治性放疗的早期声门癌患者,67%采用二维放疗/三维适形放疗,33%采用调强放疗。前连合受累者在二维放疗/三维适形放疗组5年局部无复发生存率显著更低(71% vs. 90%,p=0.03),而在调强放疗组无显著差异(81% vs. 77%,p=0.13)。作者认为调强放疗可能在一定程度上减轻前连合受累的不良影响,但需进一步研究。

要点

  • 前连合受累是早期声门癌放疗后局部控制的负面预后因素。
  • 二维放疗/三维适形放疗组中,前连合受累者5年局部无复发生存率显著更低(71% vs. 90%,p=0.03)。
  • 调强放疗组中,前连合受累与否则5年局部无复发生存率无显著差异(81% vs. 77%,p=0.13)。

核心结论

  • 前连合受累与早期声门癌放疗后局部无复发生存率较差相关,但调强放疗可能在一定程度上减轻这一不良影响,需进一步研究。

研究设计与样本

  • 回顾性分析2000年至2024年间154例接受根治性放疗的早期声门癌患者记录。
  • 67%(n=103)接受二维放疗或三维适形放疗,33%(n=51)接受调强放疗。
  • 二维放疗/三维适形放疗组中41%存在前连合受累,调强放疗组中31%存在前连合受累。
  • 中位随访87个月。

主要发现

  • 队列包括8% TisN0M0、60% T1N0M0和32% T2N0M0病例。
  • 2年和5年局部无复发生存率分别为91%和80%。
  • 二维放疗/三维适形放疗组中,前连合受累者5年局部无复发生存率显著更低(71% vs. 90%,p=0.03)。
  • 调强放疗组中,前连合受累与否则5年局部无复发生存率无显著差异(81% vs. 77%,p=0.13)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Anterior commissure involvement (ACI) is a negative prognostic factor for local control (LC) in early-stage glottic cancer (ESGC) treated with radiotherapy (RT). However, its impact in the intensity-modulated radiotherapy (IMRT) era remains unclear. This study evaluated the prognostic significance of ACI and its relationship with the RT technique. MATERIALS AND METHODS: Records of 154 ESGC patients treated with definitive RT between 2000 and 2024 were retrospectively analyzed. Conventional techniques including two-dimensional radiotherapy (2DRT) and three-dimensional conformal radiotherapy (3DCRT) were used in 67% of patients (n = 103), while 33% (n = 51) underwent IMRT. ACI was present in 41% of patients treated with 2DRT/3DCRT and 31% of those treated with IMRT. RESULTS: The cohort included 8% TisN0M0, 60% T1N0M0, and 32% T2N0M0 cases, with a median follow-up of 87 months. The 2- and 5-year local recurrence-free survival (LRFS) rate was 91% and 80%, respectively. The presence of ACI was associated with a significantly lower 5-year LRFS rate in patients treated with 2DRT/3DCRT (71% vs. 90%, p = 0.03), whereas no significant difference was observed among those treated with IMRT (81% vs. 77%, p = 0.13). CONCLUSION: Although ACI is associated with a poorer LRFS in ESGC patients receiving RT, our findings indicate that the use of IMRT may help alleviate this adverse effect to some extent. These observations warrant further investigation but may have implications for optimizing treatment strategies.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Kahvecioglu A, Yazici G, Mohammadipour S, et al. Does Anterior Commissure Involvement Matter for Early-Stage Glottic Cancer in the Intensity-Modulated Radiotherapy Era? Head Neck. 2025. PMID: 40511531. doi:10.1002/hed.28216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。